Aeglea BioTherapeutics Announces Pricing of $120 Million Public Offering – GlobeNewswireBy / April 28, 2020 Aeglea BioTherapeutics Announces Pricing of $120 Million Public Offering GlobeNewswire Share this:TweetReddit